Sg3 Management, LLC Ascendis Pharma A/S Put Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 14, 2023	BUY	$99.42 - $131.97 $745,650 - $989,775	7,500 New	7,500 $915,000
Q2 2022 Aug 15, 2022	SELL	$78.08 - $117.61 $1.51 Million - $2.28 Million	-19,400 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$102.18 - $135.75 $1.98 Million - $2.63 Million	19,400 New	19,400 $2.28 Million
Q4 2021 Feb 15, 2022	SELL	$127.1 - $169.66 $1.27 Million - $1.7 Million	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$124.92 - $173.33 $1.25 Million - $1.73 Million	10,000 New	10,000 $1.29 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.